Toxic epidermal necrolysis following thalidomide and dexamethasone treatment for multiple myeloma: a case report

Ann Hematol. 2010 Apr;89(4):421-2. doi: 10.1007/s00277-009-0810-y. Epub 2009 Aug 20.

Authors

Wan Kyu Eo, Se Hyun Kim, Seong Ha Cheon, Sang Hun Lee, Jong Soo Jeong, Yang Soo Kim, Hee Kyung Chang, Kee Suck Suh, Heung Yeol Kim

PMID: 19693501
DOI: 10.1007/s00277-009-0810-y

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antineoplastic Agents / administration & dosage
Antineoplastic Agents / adverse effects*
Antineoplastic Agents / therapeutic use
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Biopsy
Dexamethasone / administration & dosage
Dexamethasone / adverse effects*
Dexamethasone / therapeutic use
Humans
Immunoglobulins, Intravenous / immunology
Immunoglobulins, Intravenous / therapeutic use
Male
Multiple Myeloma / drug therapy*
Stevens-Johnson Syndrome / drug therapy
Stevens-Johnson Syndrome / immunology
Stevens-Johnson Syndrome / pathology*
Thalidomide / administration & dosage
Thalidomide / adverse effects*
Thalidomide / therapeutic use

Substances

Antineoplastic Agents
Immunoglobulins, Intravenous
Thalidomide
Dexamethasone